Xencor to Present at the Jefferies Virtual Healthcare Conference

Rhea-AI Summary

Xencor, Inc. (NASDAQ: XNCR) announced that Dr. Bassil Dahiyat, president and CEO, will present a corporate overview at the Jefferies Virtual Healthcare Conference on June 3, 2021, at 1:00 p.m. ET. The presentation will cover Xencor's focus on developing engineered monoclonal antibodies and cytokines for cancer and autoimmune diseases. A webcast of the event will be available on the company's website, with a replay accessible for at least 30 days following the event.

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that Bassil Dahiyat, Ph.D., president and chief executive officer, will present a corporate overview at the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021 at 1:00 p.m. ET / 10:00 a.m. PT.

A webcast will be available under "Events & Presentations" in the Investors section of the Company's website located at www.xencor.com. Following the webcast, a replay will be archived on the website for at least 30 days.

About Xencor, Inc.

Xencor is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases. Currently, 22 candidates engineered with Xencor's XmAb^® technology are in clinical development internally and with partners. Xencor's XmAb antibody engineering technology enables small changes to the structure of proteins resulting in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210527005825/en/

FAQ

When is Xencor's presentation at the Jefferies Virtual Healthcare Conference?

Xencor's presentation is scheduled for June 3, 2021, at 1:00 p.m. ET.

Who is presenting for Xencor at the Jefferies Virtual Healthcare Conference?

Dr. Bassil Dahiyat, president and CEO of Xencor, will present.

Where can I watch the Xencor presentation?

The presentation will be available via webcast on Xencor's website under the 'Events & Presentations' section.

What type of company is Xencor?

Xencor is a clinical-stage biopharmaceutical company focused on developing engineered monoclonal antibodies and cytokines for cancer and autoimmune diseases.

How many candidates are in clinical development at Xencor?

Currently, Xencor has 22 candidates in clinical development.